NEW YORK, March 17, 2026, 5:40 PM EDT
Rocket Lab shares gave up gains in post-market trading Tuesday, dropping more than 5% after the company disclosed a fresh at-the-market stock offering that could raise as much as $1 billion, according to a filing. Earlier, the space firm’s stock had ended regular hours up 10.2% at $78.59.
Rocket Lab’s decision stands out: the company is digging deeper into its war chest to bankroll expansion, despite already holding a hefty cash reserve. According to the prospectus supplement, Rocket Lab plans to funnel the net proceeds into further growth—possible acquisitions are on the table—as well as covering general corporate expenses and working capital. By the end of 2025, the company had stacked up roughly $1.1 billion across cash, cash equivalents, restricted cash, and marketable securities. That boost came in part from $280.6 million brought in through its previous ATM program during the fourth quarter.
Rocket Lab’s latest deal allows the company to sell shares intermittently, tapping banks like BofA, Goldman Sachs, Morgan Stanley, among others. Forward sale agreements are part of the package too—these deals can push back when Rocket Lab pockets the cash, unlike standard share sales.
The prospectus notes the company is scrapping its earlier $750 million stock-sale program, launched September 2025, having sold roughly $749.4 million through it. Tuesday’s filing, then, simply builds on an established funding path—it’s not a new, isolated capital raise.
That news hits less than three weeks since Rocket Lab reported a record 2025 revenue figure: $601.8 million. Quarterly revenue came in at $179.7 million, with backlog reaching $1.85 billion. For the first quarter, the company set its revenue guidance in the $185 million to $200 million range, although the first Neutron launch slipped to the fourth quarter of 2026 after a stage-one tank test failure.
Chief Financial Officer Adam Spice told analysts that first-quarter free cash flow should “remain at elevated levels,” with spending still focused on Neutron’s development and ramping up production. Chief Executive Peter Beck echoed the caution on timelines, saying, “The priority will always be to bring a reliable rocket to market”—even if that “takes a few extra months.” The Motley Fool
Neutron is Rocket Lab’s bet on its future. The medium-lift rocket is designed to move the company out of Electron’s small-launch territory and into heavier payloads—think constellations and national security contracts. That shift would nudge Rocket Lab up toward missions typically reserved for bigger players, a market where SpaceX still dominates.
Still, Rocket Lab isn’t set to dump $1 billion in stock overnight. The company said it could hit pause or stop the sales entirely—there’s no guarantee any shares get sold. The prospectus flagged possible dilution to earnings per share, and depending on how Rocket Lab’s stock performs, some settlements tied to the forward arrangements might even force the company to pay out cash.
